These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 32986996)

  • 1. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.
    Agudelo CI; Castañeda-Orjuela C; Brandileone MCC; Echániz-Aviles G; Almeida SCG; Carnalla-Barajas MN; Regueira M; Fossati S; Alarcón P; Araya P; Duarte C; Sánchez J; Novas M; Toraño-Peraza G; Rodríguez-Ortega M; Chamorro-Cortesi G; Kawabata A; García-Gabarrot G; Camou T; Spadola E; Payares D; Andrade AL; Di Fabio JL; Castañeda E;
    Lancet Infect Dis; 2021 Mar; 21(3):405-417. PubMed ID: 32986996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing trends in serotypes of S. pneumoniae isolates causing invasive and non-invasive diseases in unvaccinated population in Mexico (2000-2014).
    Carnalla-Barajas MN; Soto-Noguerón A; Sánchez-Alemán MA; Solórzano-Santos F; Velazquez-Meza ME; Echániz-Aviles G;
    Int J Infect Dis; 2017 May; 58():1-7. PubMed ID: 28216181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.
    Balsells E; Guillot L; Nair H; Kyaw MH
    PLoS One; 2017; 12(5):e0177113. PubMed ID: 28486544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan.
    Chi HC; Hsieh YC; Tsai MH; Lee CH; Kuo KC; Huang CT; Huang YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):332-336. PubMed ID: 28082066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.
    Lo SW; Gladstone RA; van Tonder AJ; Lees JA; du Plessis M; Benisty R; Givon-Lavi N; Hawkins PA; Cornick JE; Kwambana-Adams B; Law PY; Ho PL; Antonio M; Everett DB; Dagan R; von Gottberg A; Klugman KP; McGee L; Breiman RF; Bentley SD;
    Lancet Infect Dis; 2019 Jul; 19(7):759-769. PubMed ID: 31196809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
    Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory-based surveillance in Latin America: attributes and limitations in evaluation of pneumococcal vaccine impact.
    Nieto Guevara J; Guzman-Holst A
    Hum Vaccin Immunother; 2021 Nov; 17(11):4667-4672. PubMed ID: 34618660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study.
    von Gottberg A; Kleynhans J; de Gouveia L; Tempia S; Meiring S; Quan V; du Plessis M; von Mollendorf C; Crowther-Gibson P; Avenant T; du Plessis N; Kularatne R; Chibabhai V; Madhi SA; Klugman KP; Whitney CG; Cohen C;
    Lancet Glob Health; 2024 Sep; 12(9):e1470-e1484. PubMed ID: 39151982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study.
    Mackenzie GA; Hill PC; Jeffries DJ; Hossain I; Uchendu U; Ameh D; Ndiaye M; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Muhammad BS; Fombah AE; Saha D; Plumb I; Akano A; Ebruke B; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UNA; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
    Lancet Infect Dis; 2016 Jun; 16(6):703-711. PubMed ID: 26897105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population genetic structure, serotype distribution and antibiotic resistance of
    Gagetti P; Lo SW; Hawkins PA; Gladstone RA; Regueira M; Faccone D; Sireva-Argentina Group ; Klugman KP; Breiman RF; McGee L; Bentley SD; Corso A
    Microb Genom; 2021 Sep; 7(9):. PubMed ID: 34586054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotypes and antimicrobial resistance of
    León ME; Samudio M; Kawabata A; Nagai M; Rojas L; Zárate N; Irala J; Leguizamón M; Gómez G; Ortellado J; Blasco R; Franco R; Chamorro G
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37289483
    [No Abstract]   [Full Text] [Related]  

  • 15. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study.
    Choi YH; Bertran M; Litt DJ; Ladhani SN; Miller E
    Lancet Public Health; 2024 Sep; 9(9):e654-e663. PubMed ID: 39153492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.
    Singleton RJ; Hennessy TW; Bulkow LR; Hammitt LL; Zulz T; Hurlburt DA; Butler JC; Rudolph K; Parkinson A
    JAMA; 2007 Apr; 297(16):1784-92. PubMed ID: 17456820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
    Macaj M; Perdochova L; Jakubikova J
    Vaccine; 2023 Jan; 41(2):452-459. PubMed ID: 36470684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis.
    Bardach A; Ruvinsky S; Palermo MC; Alconada T; Sandoval MM; Brizuela ME; Wierzbicki ER; Cantos J; Gagetti P; Ciapponi A
    PLoS One; 2024; 19(6):e0304978. PubMed ID: 38935748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.